Mpsgcwgcwr

Chemo Secrets From a Breast Cancer Survivor

Breast Cancer Survivors

Get Instant Access

Express these mutations using the accepted nomenclature.

References

1. Yeung A, Hattangadi D, Blakesley L, et al. Enzymatic mutation detection technologies. BioTechniques 2005;38(5):749-58.

2. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel elec-trophoresis as single-strand conformation polymorphisms. Proceedings of the National Academy of Sciences 1989;86:2766-70.

3. Orita M, Suzuki Y, Sekiya T, et al. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989;5:874-79.

4. Hayashi K. A simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods and Applications 1991;1:34-38.

5. Atha D, Wenz H-M, Morehead H, et al. Detection of p53 point mutations by single strand conformation polymorphism: Analysis by capillary elec-trophoresis Electrophoresis 1998;19:172-79.

6. Ellison J, Dean M, Goldman D. Efficacy of fluorescence-based PCR-SSCP for detection of point mutations. BioTechniques 1993;15:684-91.

7. Soong R, Iacopetta BJ. A rapid nonisotopic method for the screening and sequencing of p53 gene mutations in formalin-fixed, paraffin-embedded tumors. Modern Pathology 1997;10:252-58.

8. Sarkar G, Sommer SS. Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): Comparison with DNA-SSCP. Nucleic Acids Research 1992;20(4):871-78.

9. Bisceglia L, Grifa A, Zelante L, et al. Development of RNA-SSCP protocols for the identification and screening of CFTR mutations: Identification of two new mutations. Human Mutation 1994;4(2):136-40.

10. Liu Q, Sommer SS. Restriction endonuclease fingerprinting (REF): A sensitive method for screening mutations in long contiguous segments of DNA. BioTechniques 1995;18(3):470-77.

11. Fodde RLM. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Human Mutation 1994;3(2):83-94.

12. Fisher S, Lerman LS. Length-independent separation of DNA restriction fragments in two-dimensional gel electrophoresis. Cell 1979;16:191-200.

13. Fischer S, Lerman LS. DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: Correspondence with melting theory. Proceedings of the National Academy of Sciences 1983;80(6):1579-83.

14. Hayes V, Bleeker W, Verind E, et al. Comprehensive TP53-denaturing gradient gel elec-trophoresis mutation detection assay also applicable to archival paraffin embedded tissue. Diagnostic Molecular Pathology 1999;8(1):2-10.

15. Brady S, Magro CM, Diaz-Cano SJ, et al. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE. Human Pathology 1999;30(2):130-36.

16. Miller K, Ming TJ, Schulze AD, et al. Denaturing gradient gel electrophoresis (DGGE): A rapid and sensitive technique to screen nucleotide sequence variation in populations. BioTechniques 1999;27: 1016-30.

17. Burmeister M, diSibio G, Cox DR, et al. Identification of polymorphisms by genomic denaturing gradient gel electrophoresis: Application to the proximal region of human chromosome 21. Nucleic Acids Research 1991;19(7):1475-81.

18. Borresen A, Hovig E, Smith-Sorensen B, et al. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proceedings of the National Academy of Sciences 1991;88: 8405-8409.

19. Smith-Sorensen B, Hovig E, Andersson B, et al. Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophore-sis (CDGE). Mutation Research 1992;269(1): 41-53.

20. Yoshino K, Nishigaki K, Husimi Y. Temperature sweep gel electrophoresis: A simple method to detect point mutations. Nucleic Acids Research 1991;19:3153.

21. Wiese U, Wulfert M, Prusiner S, et al. Scanning for mutations in the human prion protein open reading frame by temporal temperature gradient gel elec-trophoresis. Electrophoresis 1995;16:1851-60.

22. Khrapko K, Hanekamp JS, Thilly WG, et al. Constant denaturant capillary electrophoresis (CDCE): A high resolution approach to mutational analysis. Nucleic Acids Research 1994;22:364-69.

23. Borresen A-L, Hovig E, Smith-Sorensen B, et al. Mutation analysis in human cancers using PCR and constant denaturant gel electrophoresis (CDGE). Advances in Molecular Genetics 1991;4:63-71.

24. Taniere P, Martel-Planche G, Maurici D, et al. Molecular and clinical differences between adeno-carcinomas of the esophagus and of the gastric cardia. American Journal of Pathology 2001;158(1): 33-40.

25. Lindforss U, Zetterquist H, Papadogiannakis N, et al. Persistence of K-ras mutations in plasma after colorectal tumor resection. Anticancer Research 2005;25:657-61.

26. Balogh KPA, Patocs A, Majnik J, et al. Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. Molecular Genetics and Metabolism 2004;83 (1-2):74-81.

27. Bor M, Balogh K, Pusztai A, et al. Genetic screening of exon 12 of the hydroxymethylbilane synthase enzyme of patients with acute intermittent por-phyria. Journal of Physiology 2000;526:111P.

28. Hernan-Gomez SEJ, Espinosa JC, Ubeda JF. Characterization of wine yeasts by temperature gradient gel electrophoresis (TGGE). FEMS Microbiology Letters 2000;193(1):45-50.

29. Tominaga T. Rapid identification of pickle yeasts by fluorescent PCR and microtemperature-gradient gel electrophoresi. FEMS Microbiol Letters 2004;238 (1):43-48.

30. Struewing J, Hartge P, Wacholder S, et al. The risk of cancer associated with the 185delAG and 5382insC mutations of BRCA1 and the 6174delT mutation of BRCA2 among Ashkenazi Jews. New England Journal of Medicine 1997;336(20): 1401-1408.

31. Hussussian C, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nature Genetics 1994;8:15-21.

32. Roa B, Boyd AA, Volcik K, et al. Ashkenazi Jewish population frequencies for common mutations in

BRCA1 and BRCA2. Nature Genetics 1996;14: 185-87.

33. 0rum H, Jakobsen MH, Koch T, et al. Detection of the factor V Leiden mutation by direct allele-specific hybridization of PCR amplicons to photoimmobilized locked nucleic acids. Clinical Chemistry 1999;45:1898-1905.

34. Wittwer C, Gudrun HR, Gundry CN, et al. Highresolution genotyping by amplicon melting analysis using LC Green. Clinical Chemistry 2003;49(6): 853-60.

35. Ririe K, Rasmussen RP, Wittwer CT. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Analytical Biochemistry 1997;245:154-60.

36. Lay M, Wittwer CT. Real-time fluorescence geno-typing of factor V Leiden during rapid cycle PCR. Clinical Chemistry 1997;43:2262-67.

37. Lyon E. Mutation detection using fluorescent hybridization probes and melting curve analysis. Expert Reviews in Molecular Diagnostics 2001;1(1):92-101.

38. Pals G. Detection of a single base substitution in single cells by melting peak analysis using dual color hybridization probes. In Dietmaier W, Wittwer C, Sivasubramanian N, eds. Rapid Cycle Real-Time PCR Methods and Applications. Springer, 2002, pp. 77-84.

39. Reed G, Wittwer CT. Sensitivity and specificity of single-nucleotide polymorphism scanning by highresolution melting analysis. Clinical Chemistry 2004;50(10):1748-54.

40. Kutyavin I, Afonina IA, Mills A, et al. 3'-minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Research 2000;28(2):655-61.

41. Bennett C, Campbell MN, Cook CJ, et al. The LightTyper: High-throughput genotyping using fluorescent melting curve analysis. BioTechniques 2003;34(6):1288-92.

42. de Kok J, Wiegerinck ET, Giesendorf BA, et al. Rapid genotyping of single nucleotide polymorphisms using novel minor groove binding DNA oligonucleotides (MGB probes). Human Mutation 2002;19(5):554-59.

43. Van Hoeyveld EHF, Massonet C, Moens L, et al. Detection of single nucleotide polymorphisms in the mannose-binding lectin gene using minor groove binder-DNA probes. Journal of Immunological Methods 2004;287(1-2):227-30.

44. Belousov Y, Welch RA, Sanders S, et al. Single nucleotide polymorphism genotyping by two-colour melting curve analysis using the MGB Eclipse Probe System in challenging sequence environment. Human Genomics 2004;1(3): 209-17.

45. Fujigaki H, Takemura M, Takahashi K, et al. Genotyping of hepatitis C virus by melting curve analysis with SYBR Green I. Annals of Clinical Biochemistry 2004;41(2):130-32.

46. Hardenbol P, Baner J, Jain M, et al. Multiplexed genotyping with sequence-tagged molecular inversion probes. Nature Biotechnology 2003;21(6): 673-78.

47. Hardenbol P, Yu F, Belmont J, et al. Highly multiplexed molecular inversion probe genotyping: Over 10,000 targeted SNPs genotyped in a single tube assay. Genome Research 2005;15(2):269-75.

48. Belda F, Barlow KL, Clewley JP. Subtyping HIV-1 by improved resolution of heteroduplexes on agarose gels. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1997;16(3):218-19.

49. Gonzalez M, Gonzalez D, Lopez-Perez R, et al. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma: A comparison between different strategies. Haematologica 1999;84(9):779-84.

50. Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: Evidence for solvent-induced bends in DNA heteroduplexes. Proceedings of the National Academy of Sciences 1993;90:10325-29.

51. Ganguly A. An update on conformation sensitive gel electrophoresis. Human Mutation 2002;19(4): 334-42.

52. Rees W, Yager TD, Korte J, et al. Betaine can eliminate the base pair composition dependence of DNA melting. Biochemistry 1993;32(1):137-44.

53. O'Donovan M, Oefner PJ, Robers SC, et al. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 1998;15(1):44-49.

54. Keller G, Hartmann A, Mueller J, et al. Denaturing high-pressure liquid chromatography (DHPLC) for the analysis of somatic p53 mutations. Laboratory Investigation 2001;81(12):1735-37.

55. Narayanswami G, Taylor PD. Improved efficiency of mutation detection by denaturing highperformance liquid chromatography using modified primers and hybridization procedure. Genetic Testing 2001;5(1):9-16.

56. Schollen E, Dequeker E, McQuaid S, et al. Diagnostic DHPLC quality assurance (DDQA): A collaborative approach to the generation of validated and standardized methods for DHPLC-based mutation screening in clinical genetics laboratories. Human Mutation 2005;25(6):583-92.

57. Wen W, Bernstein L, Lescallett J, et al. Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis. Cancer Research 2000;60(10):2716-22.

58. Moutereau S, Narwa R, Matheron C, et al. An improved electronic microarray-based diagnostic assay for identification of MEFV mutations. Human Mutation 2004;23(6):621-28.

59. Lopez-Crapez E, Livache T, Marchand J, et al. K-ras mutation detection by hybridization to a polypyrrole DNA chip. Clinical Chemistry 2001; 47:186-94.

60. Fedrigo O, Naylor G. A gene-specific DNA sequencing chip for exploring molecular evolutionary change. Nucleic Acids Research 2004;32(3): 1208-13.

61. Fulton R, McDade RL, Smith PL, et al. Advanced multiplexed analysis with the FlowMetrix system. Clinical Chemistry 1997;43(9):1749-56.

62. Martins T. Development of internal controls for the Luminex instrument as part of a multiplex seven-analyte viral respiratory antibody profile. Clinical and Diagnostic Laboratory Immunology 2002;9(1): 41-45.

63. Bortolin S, Black M, Modi H, et al. Analytical validation of the tag-it high-throughput microsphere-based universal array genotyping platform: Application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms. Clinical Chemistry 2004;50(11):2028-36.

64. Biagini R, Sammons DL, Smith JP, et al. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clinical and Diagnostic Laboratory Immunology 2004;11(11):50-55.

65. Ye S, Humphries S, Green F. Allele-specific amplification by tetra-primer PCR. Nucleic Acids Research 1992;20(5):1152.

66. Ye S, Dhillon S, Ke X, et al. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Research 2001;29(17).

67. Oliphant A, Barker DL, Stuelpnagel JR, et al. Bead Array technology: Enabling an accurate, cost-effective approach to high-throughput genotyping. BioTechniques 2002;32:s56-s61.

68. Louis M, Dekairelle AF, Gala JL. Rapid combined genotyping of factor V, prothrombin and methyl-enetetrahydrofolate reductase single nucleotide polymorphisms using minor groove binding DNA oligonucleotides (MGB probes) and realtime polymerase chain reaction. Clinical Chemistry and Laboratory Medicine 42 2004;12 (1364-1369).

69. Behrens M, Lange R. A highly reproducible and economically competitive SNP analysis of several well characterized human mutations. Clinical Laboratory 2004;50(5-6):305-16.

70. Osgood-McWeeneya D, Galluzzi JR, Ordovas JM. Allelic discrimination for single nucleotide polymorphisms in the human scavenger receptor class B type 1 gene locus using fluorescent probes. Clinical Chemistry 2000;46:118-19.

71. Gopalraj R, Zhu H, Kelly JF, et al. Genetic association of low density lipoprotein receptor and Alzheimer's disease. Neurobiology and Aging 2005;26(1):1-7.

72. Hughes D, Ginolhac SM, Coupier I, et al. Common BRCA2 variants and modification of breast and ovarian cancer risk in BRCA1 mutation carriers. Cancer Epidemiology Biomarkers and Prevention 2005;14(1):265-67.

73. Campsall P, Au NH, Prendiville JS, et al. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. Journal of Clinical Microbiology 2004;42(4):1409-13.

74. Easterday W, Van Ert MN, Zanecki S, et al. Specific detection of Bacillus anthracis using TaqMan mismatch amplification mutation assay. BioTechniques 2005;38(5):731-35.

75. Lancaster J, Berchuck A, Futreal PA, et al. Dideoxy fingerprinting assay for BRCA1 mutation analysis. Molecular Carcinogenesis 1997;19(3):176-79.

76. Liu Q, Feng J, Sommer SS. Bidirectional dideoxy fingerpringing (Bi-ddF): A rapid method for quantitative detection of mutations in genomic regions of 300-600 bp. Human Molecular Genetics 1993;5(1): 107-14.

77. Larsen L, Johnson M, Brown C, et al. Automated mutation screening using dideoxy fingerprinting and capillary array electrophoresis. Human Mutation 2001;18(5):451-57.

78. Larsen L, Christiansen M, Vuust J, et al. High throughput mutation screening by automated capillary electrophoresis. Combinatorial Chemistry and High Throughput Screening 2000;3:393-409.

79. Hsu T, Chen X, Duan S, et al. Universal SNP geno-typing assay with fluorescence polarization detection. BioTechniques 2001;31(3):560-70.

80. Chen X, Levine L, Kwok P-Y. Fluorescence polarization in homogeneous nucleic acid analysis. Genome Research 1999;9(5):492-98.

81. Xiao M, Latif SM, Kwok P-Y. Kinetic FP-TDI assay for SNP allele frequency determination. BioTechniques 2003;34(1):190-97.

82. Leushner J, Chiu NH. Automated mass spectrome-try: A revolutionary technology for clinical diagnostics. Molecular Diagnostics 2000;5(4):341-48.

83. Jurinke C, Oeth P, van den Boom D. MALDI-TOF mass spectrometry: A versatile tool for high-performance DNA analysis. Molecular Biotechnology 2004;26(2):147-64.

84. Hung K, Sun X, Ding H, et al. A matrix-assisted laser desorption/ionization time-of-flight-based method for screening the 1691G: A mutation in the factor V gene. Blood Coagulation and Fibrinolysis 2002;13(2):117-22.

85. Stanssens P, Zabeau M, Meersseman G, et al. High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. Genome Research 2004; 14(1):126-33.

86. Tost J, Gut IG. Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clini cal applications. Clinical Biochemistry 2005;38(4): 335-50.

87. Buyse I, McCarthy SE, Lurix P, et al. Use of MALDI-TOF mass spectrometry in a 51-mutation test for cystic fibrosis: Evidence that 3199del6 is a disease-causing mutation. Genetics in Medicine 2005;6(5):426-30.

88. Roest P, Roberts RG, Sugino S, et al. Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Human Molecular Genetics 1993;2:1719-21.

89. Zikan M, Pohlreich P , Stribrna J. Mutational analysis of the BRCA1 gene in 30 Czech ovarian cancer patients. Journal of Genetics 2005;84(1): 63-67.

90. Hogervorst F, Cornelis R, Bout M, et al. Rapid detection of BRCA1 mutations by the protein truncation test. Nature Genetics 1995;10:208-12.

91. Romey M, Tuffery S, Desgeorges M, et al. Transcript analysis of CFTR frameshift mutations in lymphocytes using the reverse transcription-poly-merase chain reaction technique and the protein truncation test. Human Genetics 1996;98(3):328-32.

92. van der Luijt R, Khan PM, Vasen H, et al. Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 1994;20(1):1-4.

93. Tsai T, Fulton L, Smith BJ, et al. Rapid identification of germline mutations in retinoblastoma by protein truncation testing. Archives of Ophthalmology 2004;122:239-48.

94. Gold B, Hanson M, Dean M. Two rare confounding polymorphisms proximal to the factor V Leiden mutation. Molecular Diagnostics 2001;6(2):137-40.

95. DiSiena M, Intres R, Carter DJ. Factor V Leiden and pulmonary embolism in a young woman taking an oral contraceptive. American Journal of Forensic Medical Pathology 1998;19(4):362-67.

96. Baris I, Koksal V, Etlik O. Multiplex PCR-RFLP assay for detection of factor V Leiden and prothrombin G20210A. Genetic Testing 2004;8(4):381.

97. Huber S, McMaster KJ, Voelkerding KV. Analytical evaluation of primer engineered multiplex poly-merase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A. Journal of Molecular Diagnostics 2000;2:153-57.

98. Lucotte G, Champenois T. Duplex PCR-RFLP for simultaneous detection of factor V Leiden and prothrombin G20210A. Molecular and Cellular 110. Probes 2003;17(5):267-69. 99. Welbourn J, Maiti S, Paley J. Factor V Leiden detection by polymerase chain reaction-restriction fragment length polymorphism with mutagenic 111. primers in a multiplex reaction with Pro G20210A: A novel technique. Hematology 2003;8(2):73-75.

100. Howard J, Ward J, Watson JN, et al. Heteroduplex cleavage analysis using S1 nuclease. BioTechniques 1999;27(1):18-19. 112.

101. Hawkins G, Hoffman LM. Base excision sequence scanning. Nature Biotechnology 1997;15(8): 803-804.

102. Hawkins G, Hoffman LM. Rapid DNA mutation identification and fingerprinting using base exci- 113. sion sequence scanning. Electrophoresis 1999;20 (6):1171-76.

103. Goldrick M, Kimball GR, Liu Q, et al. NIRCA: A

rapid robust method for screening for unknown 114.

point mutations. BioTechniques 1996;21(1): 106-12.

104. Macera M, Godec CJ, Sharma N, et al. Loss of heterozygosity of the TP53 tumor suppressor gene and detection of point mutations by the non-isotopic RNAse cleavage assay in prostate cancer.

Cancer Genetics and Cytogenetics 1999;108(1): 115. 42-47.

105. Shen D, Wu Y, Subbarao M, et al. Mutation analysis of BRCA1 gene in African-American patients with breast cancer. Journal of the National 116.

Medical Association 2000;92(1):29-35.

106. Shen D, Wu Y, Chillar R, et al. Missense alterations of BRCA1 gene detected in diverse cancer patients. Anticancer Research 2000;20:1129-32. 117.

107. Lyamichev V, Mast AL, Hall JG, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonu- 118. cleotide probes. Nature Biotechnology 1999;17(3): 292-96.

108. Hall J, Eis PS, Law SM, et al. Sensitive detection 119. of DNA polymorphisms by the serial invasive signal amplification reaction. Proceedings of the

National Academy of Sciences 2000;97:8272-77. 120.

109. Kwiatkowski RW, de Arruda M, Neri B. Clinical, genetic, and pharmacogenetic applications of the

Invader assay. Molecular Diagnostics 1999;4(4): 353-64.

Hessner M, Budish MA, Friedman KD. Genotyp-ing of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clinical Chemistry 2000;46(8):1051-1056. Patnaik M, Dlott JS, Fontaine RN, et al. Detection of genomic polymorphisms associated with venous thrombosis using the invader biplex assay. Journal of Molecular Diagnostics 2004;6(2):137-44.

Ryan D, Nuccie B, Arvan D. Non-PCR-dependent detection of the factor V Leiden mutation from genomic DNA using a homogeneous invader microtiter plate assay. Molecular Diagnostics 1999;4(2):135-44.

Hjertner B, Meehan B, McKillen J, et al. Adaptation of an invader assay for the detection of African swine fever virus DNA. Journal of Virological Methods 2005;124(1-2):1-10. Cotton R, Rodrigues NR, Campbell RD. Reactivity of cytosine and thymine in single base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proceedings of the National Academy of Sciences 1988;85(12): 4397-4401.

Fuhrmann M, Oertel W, Berthold P, et al. Removal of mismatched bases from synthetic genes by enzymatic mismatch cleavage. Nucleic Acids

Research 2005;33(6):e58.

Freson K, Peerlinck K, Aguirre T, et al.

Fluorescent chemical cleavage of mismatches for efficient screening of the factor VIII gene. Human

Mutation 1999;11(6):470-79.

Rowley G, Saad S, Gianelli F, et al. Ultrarapid mutation detection by multiplex, solid-phase chemical cleavage. Genomics 1995;30:574-82.

Enzymatic mutation detection in the P53 gene.

Clinical Chemistry 2000;46:1562-73.

Qiu P, Shandilya H, D'Alessio JM, et al. Mutation detection using Surveyor nuclease. BioTechniques

Tessitore A, Di Rocco ZC, Cannita K, et al. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis. Genes Chromosomes Cancer 2002; 35(1):86-91.

121. Benoit N, Goldenberg D, Deng SX, et al. Colori-metric approach to high-throughput mutation analysis. BioTechniques 2005;38(4):635-39.

122. Espasa M, Gonzalez-Martin J, Alcaide F, Aragon LM, et al. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. Journal of Antimicrobial Chemotherapy 2005;55:860-65.

123. Antonarakis S, Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Human Mutation 1998; 11:1-3.

124. den Dunnen J, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations. Human Mutation 2000;15: 7-12.

125. Barros F, Lareu MV, Salas A, et al. Rapid and enhanced detection of mitochondrial DNA variation using single-strand conformation analysis of superposed restriction enzyme fragments from polymerase chain reaction-amplified products. Electrophoresis 1997;18(1):52-54.

126. Hayashi K, Yandell DW. How sensitive is PCR-SSCP? Human Mutation 1993;2(5):338-46.

127. Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Human Mutation 1994;3(2):83-94.

128. Hanekamp J, Thilly WG, Chaudhry MA. Screening for human mitochondrial DNA polymorphisms with denaturing gradient gel elec-trophoresis. Human Genetics 1996;98:243-45.

129. Chen T-J, Boles RG, Wong L-JC. Detection of mitochondrial DNA mutations by temporal temperature gradient gel electrophoresis. Clinical Chemistry 1999;45:1162-67.

130. Wang Y, Helland A, Holm R, et al. TP53 mutations in early-stage ovarian carcinoma: Relation to long-term survival. British Journal of Cancer 2004;90:678-85.

131. Wallace R, Shaffer J, Murphy RF, et al. Hybridization of synthetic oligodeoxyribonucleotides to phi chi 174 DNA: The effect of single base-pair mismatch. Nucleic Acids Research 1979;6 (11):3543.

132. Stamer U, Bayerer B, Wolf S, et al. Rapid and reliable method for cytochrome P450 2D6 genotyping. Clinical Chemistry 2002;48(9): 1412-17.

133. Yamanoshita O, Kubota T, Hou J, et al. DHPLC is superior to SSCP in screening p53 mutations in esophageal cancer tissues. International Journal of Cancer 2005;114(1):74-79.

134. Premstaller A, Oefner PJ. Denaturing HPLC of nucleic acids. PharmaGenomics 2003;20: 21-37.

135. Metaxa-Mariatou V, Papadopoulos S, Papado-poulou E, et al. Molecular analysis of GISTs: Evaluation of sequencing and dHPLC. DNA and Cell Biology 2004;23(11):777-82.

136. Hecker K, Taylor PD, Gjerde DT. Mutation detection by denaturing DNA chromatography using fluorescently labeled polymerase chain reaction products. Analytical Biochemistry 1999;272: 156-64.

137. Bahrami A, Dickman MJ, Matin MM, et al. Use of fluorescent DNA-intercalating dyes in the analysis of DNA via ion-pair reversed phase denaturing high-performance liquid chromatography. Analytical Biochemistry 2002;309:248-52.

138. Heller M, Forster AH, Tu E. Active microeletronic chip devices which utilize controlled electrophore-tic fields for multiplex DNA hybridization and other genomic applications. Electrophoresis 2000; 21(1):157-64.

139. Juszczynski P, Woszczek G, Borowiec M, et al. Comparison study for genotyping of a single-nucleotide polymorphism in the tumor necrosis factor promoter gene. Diagnostic Molecular Pathology 2002;11(4):228-33.

140. Ellis M. "Spot-on" SNP genotyping. Genome Research 2000;10(7):895-97.

141. Geisler J, Hatterman-Zogg MA, Rathe JA, et al. Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms singlestrand conformation polymorphism analysis (SSCP). Human Mutation 2001;18(4):337-44.

142. Brieger A, Trojan J, Raedle J, et al. Identification of germline mutations in hereditary nonpolyposis colorectal cancer using base excision sequence scanning analysis. Clinical Chemistry 1999;45: 1564-67.

143. Matsuno N, Nanri T, Kawakita T, et al. A novel FLT3 activation loop mutation N841K in acute myeloblastic leukemia. Leukemia 2005;19:480-81.

144. Waldron-Lyncha F, Adamsa C, Shanahanb F, et al. Genetic analysis of the 3' untranslated region of the tumour necrosis factor shows a highly conserved region in rheumatoid arthritis-affected and -unaffected subjects. Journal of Medical Genetics 1999;36:214-16.

Biology

145. Hessner M, Friedman KD, Voelkerding K, et al. Multisite study for genotyping of the factor

II (prothrombin) G20210A mutation by the Invader assay. Clinical Chemistry 2001;47: 2048-50.

146. Sheffield V, Beck JS, Kwitek AE, et al. The sensitivity of single-strand conformation polymorphism analysis for the detection of single base substitutions. Genomics 1993;16(2):325.

Chapter

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment